A carregar...
Current Status of Baricitinib as a Repurposed Therapy for COVID-19
The emergence of the COVID-19 pandemic has mandated the instant (re)search for potential drug candidates. In response to the unprecedented situation, it was recognized early that repurposing of available drugs in the market could timely save lives, by skipping the lengthy phases of preclinical and i...
Na minha lista:
| Publicado no: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8308612/ https://ncbi.nlm.nih.gov/pubmed/34358107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14070680 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|